keyword
https://read.qxmd.com/read/38696655/brain-metastasis-from-egfr-mutated-non-small-cell-lung-cancer-secretion-of-il11-from-astrocytes-up-regulates-pdl1-and-promotes-immune-escape
#1
JOURNAL ARTICLE
Mengyi Tang, Mingxin Xu, Jian Wang, Ye Liu, Kun Liang, Yinuo Jin, Wenzhe Duan, Shengkai Xia, Guohui Li, Huiying Chu, Wenwen Liu, Qi Wang
Patients who have non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations are more prone to brain metastasis (BM) and poor prognosis. Previous studies showed that the tumor microenvironment of BM in these patients is immunosuppressed, as indicated by reduced T-cell abundance and activity, although the mechanism of this immunosuppression requires further study. This study shows that reactive astrocytes play a critical role in promoting the immune escape of BM from EGFR-mutated NSCLC by increasing the apoptosis of CD8+ T lymphocytes...
May 2, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38682176/fibroblast-derived-interleukin-6-exacerbates-adverse-cardiac-remodeling-after-myocardial-infarction
#2
JOURNAL ARTICLE
Hongkun Li, Yunfei Bian
Myocardial infarction is one of the leading causes of mortality globally. Currently, the pleiotropic inflammatory cytokine interleukin-6 (IL-6) is considered to be intimately related to the severity of myocardial injury during myocardial infarction. Interventions targeting IL-6 are a promising therapeutic option for myocardial infarction, but the underlying molecular mechanisms are not well understood. Here, we report the novel role of IL-6 in regulating adverse cardiac remodeling mediated by fibroblasts in a mouse model of myocardial infarction...
May 1, 2024: Korean Journal of Physiology & Pharmacology
https://read.qxmd.com/read/38679415/targeting-il-11-to-reduce-fibrocyte-circulation-and-lung-accumulation-in-animal-models-of-pulmonary-hypertension-associated-lung-fibrosis
#3
JOURNAL ARTICLE
Javier Milara, Inés Roger, Paula Montero, Enrique Artigues, Juan Escrivá, Raquel Del Río, Julio Cortijo
BACKGROUND AND PURPOSE: IL-11 is a member of the IL-6 family of cytokine initially considered as haematopoietic and cytoprotective factor. Recent evidence indicates that IL-11 promotes lung fibrosis and pulmonary hypertension in animal models and is elevated in lung tissue of patients with pulmonary fibrosis and pulmonary hypertension. Fibrocytes are bone marrow-derived circulating cells that participate in lung fibrosis and pulmonary hypertension, but the role of IL-11 on fibrocytes is unknown...
April 28, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38643817/serum-levels-of-il-9-and-il-11-serve-as-predictors-for-the-occurrence-of-early-neurologic-deterioration-in-patients-with-cerebral-infarction
#4
JOURNAL ARTICLE
Xianglin Guo, Xiaoyan Zhu, Shuai Zhou, Xiaohong Dong
BACKGROUND AND AIM: Early neurological deterioration (END) is a common complication of cerebral infarction and a significant contributor to poor prognosis. Our study aimed to investigate the predictive value of interleukin-9 (IL-9) and interleukin-11 (IL-11) in relation to the occurrence of END in patients with cerebral infarction. MATERIALS AND METHODS: 102 patients with cerebral infarction and 64 healthy controls were collected. Patients were categorized into two groups based on the development of END following admission: the END group (n = 44) and the non-END group (n = 58)...
April 19, 2024: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://read.qxmd.com/read/38627168/potential-therapeutic-targets-of-fibrosis-in-inflammatory-rheumatic-diseases
#5
REVIEW
Jiang Su, Julianna Desmarais, Cong-Qiu Chu, Jing Zhu
Fibrosis is commonly associated with chronic rheumatic diseases, and causes substantial morbidity and mortality. Treatment of fibrosis is extremely challenging but is badly needed, as approved antifibrotic therapies fibrosis do not halt its progression, which will be discussed with a focus on pulmonary fibrosis. Findings from recent studies indicate several therapeutic targets for treating fibrosis. Interleukin-11 is emerging as a fibrogenic cytokine whose activity can be blocked with neutralizing monoclonal antibodies...
April 15, 2024: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/38561103/pirfenidone-and-nintedanib-attenuates-pulmonary-artery-endothelial-and-smooth-muscle-cells-transformations-induced-by-il-11
#6
JOURNAL ARTICLE
Inés Roger, Paula Montero, Javier Milara, Julio Cortijo
Idiopathic pulmonary fibrosis (IPF) associated to pulmonary hypertension (PH) portends a poor prognosis, characterized by lung parenchyma fibrosis and pulmonary artery remodeling. Serum and parenchyma levels of Interleukin 11 (IL-11) are elevated in IPF-PH patients and contributes to pulmonary artery remodeling and PH. However, the effect of current approved therapies against IPF in pulmonary artery remodeling induced by IL-11 is unknown. The aim of this study is to analyze the effects of nintedanib and pirfenidone on pulmonary artery endothelial and smooth muscle cell remodeling induced by IL-11 in vitro...
March 30, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38551695/exploring-the-role-of-interleukin-11-in-cancer-progression-patient-survival-and-therapeutic-insights
#7
JOURNAL ARTICLE
Mahsa Hassani, Mohammad Mahdevar, Maryam Peymani
BACKGROUND: The Interleukin (IL)-11 gene, which is one of the members of the cytokine family, has an oncogenic role in some cancers. The main goal of this study is to analyze IL-11 expression level in 14 prevalent cancers and highlights its role in patients' survival, drug resistance, and sensitivities. Also, an association of this gene with metastasis and inflammation pathways has been investigated. METHODS AND RESULTS: Using the cancer genome atlas (TCGA) data, the level of IL-11 expression and its role in prognosis and survival rate were evaluated in 13 common cancers...
March 29, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38542101/identification-of-serum-biomarkers-to-monitor-therapeutic-response-in-intestinal-type-gastric-cancer
#8
JOURNAL ARTICLE
Laura F Dagley, Jumana Yousef, Adele Preaudet, Andrea Loving, Andrew I Webb, Matthias Ernst, Tracy L Putoczki
There are a limited number of clinically useful serum biomarkers to predict tumor onset or treatment response in gastric cancer (GC). For this reason, we explored the serum proteome of the gp130 Y757F murine model of intestinal-type gastric cancer (IGC). We identified 30 proteins with significantly elevated expression in early gp130 Y757F IGC and 12 proteins that were significantly elevated in late gp130 Y757F IGC compared to age- and gender-matched wild-type mice. Within these signatures, there was an overlap of 10 proteins commonly elevated in both early- and late-stage disease...
March 8, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38515388/a-real-world-observation-on-thrombopoietic-agents-for-patients-with-cancer-treatment-induced-thrombocytopenia-in-china-a-multicenter-cross-sectional-study
#9
JOURNAL ARTICLE
Meiting Chen, Lu Li, Qing Xia, Xiaobing Chen, Zijun Liao, Chang Wang, Bo Shen, Min Zhou, Qingyuan Zhang, Yanqiao Zhang, Liting Qian, Xianglin Yuan, Zhehai Wang, Cong Xue, Xin An, Bin Liu, Kangsheng Gu, Mei Hou, Xiaojia Wang, Wei Wang, Enxiao Li, Jincai Zhong, Jing Cheng, Yongqian Shu, Nong Yang, Huaqing Wang, Runxiang Yang, Tianshu Liu, Ting Deng, Fei Ma, Wangjun Liao, Wensheng Qiu, Yu Chen, Xi Chen, Mingzhi Zhang, Ruilian Xu, Xiaoling Li, Jifeng Feng, Yi Ba, Yanxia Shi
BACKGROUND: Studies on various thrombopoietic agents for cancer treatment-induced thrombocytopenia (CTIT) in China are lacking. This study aimed to provide detailed clinical profiles to understand the outcomes and safety of different CTIT treatment regimens. METHODS: In this retrospective, cross-sectional study, 1664 questionnaires were collected from 33 hospitals between March 1 and July 1, 2021. Patients aged >18 years were enrolled who were diagnosed with CTIT and treated with recombinant interleukin 11 (rhIL-11), recombinant thrombopoietin (rhTPO), or a thrombopoietin receptor agonist (TPO-RA)...
March 22, 2024: Cancer
https://read.qxmd.com/read/38468436/inhibiting-il11ra-to-mitigate-hepatic-metastasis-in-skin-cutaneous-melanoma-comprehensive-insights-from-in-vitro-and-in-vivo-investigations
#10
JOURNAL ARTICLE
Zhen-Guo Zhang, Hong-Mei Zhu, Huai-Kang Hua
OBJECTIVE: This study aimed to investigate the role of Interleukin-11 receptor alpha (IL11RA) in skin cutaneous melanoma (SKCM) metastasis to the liver. METHODS: Human SKCM cell lines (A375, A375-MA2, SK-MEL-28, RPMI-7951) and primary dermal fibroblasts (HDFa) were utilized to assess IL11RA expression. IL11RA siRNA was transfected into RPMI-7951 and A375-MA2 cells for Wound healing and Transwell invasion assays. Il11ra knockout (KO) mice and wild-type (WT) mice were injected with B16-F10 cells into the spleen to evaluate hepatic melanoma metastasis...
March 2024: Skin Research and Technology
https://read.qxmd.com/read/38455057/il11-mediated-stromal-cell-activation-may-not-be-the-master-regulator-of-pro-fibrotic-signaling-downstream-of-tgf%C3%AE
#11
JOURNAL ARTICLE
Yunhao Tan, Kenta Mosallanejad, Qingxiu Zhang, Stephen O'Brien, Meghan Clements, Stuart Perper, Sarah Wilson, Sudiksha Chaulagain, Jing Wang, Mary Abdalla, Helen Al-Saidi, Danyal Butt, Anca Clabbers, Kwasi Ofori, Beth Dillon, Bohdan Harvey, John Memmott, Christopher Negron, David Winarta, Catherine Tan, Amlan Biswas, Feng Dong, Vanessa Morales-Tirado, Xiaoqing Lu, Gurminder Singh, Michael White, Shanna Ashley, Heather Knight, Susan Westmoreland, Lucy Phillips, Tracy Carr, Lauren Reinke-Breen, Rajeeva Singh, Jianwen Xu, Kan Wu, Lisa Rinaldi, Brian Stoll, Yupeng David He, Lisa Hazelwood, Jozsef Karman, Andrew McCluskey, William Stine, Ivan Correia, Stephen Gauld, Marc C Levesque, Geertruida Veldman, Cedric Hubeau, Timothy Radstake, Ramkrishna Sadhukhan, Edda Fiebiger
Fibrotic diseases, such as idiopathic pulmonary fibrosis (IPF) and systemic scleroderma (SSc), are commonly associated with high morbidity and mortality, thereby representing a significant unmet medical need. Interleukin 11 (IL11)-mediated cell activation has been identified as a central mechanism for promoting fibrosis downstream of TGFβ. IL11 signaling has recently been reported to promote fibroblast-to-myofibroblast transition, thus leading to various pro-fibrotic phenotypic changes. We confirmed increased mRNA expression of IL11 and IL11Rα in fibrotic diseases by OMICs approaches and in situ hybridization...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38442937/-effect-of-recombinant-human-thrombopoietin-on-platelets-in-rats-with-d-galactosamine-salt-induced-acute-liver-failure
#12
JOURNAL ARTICLE
Fei Tang, Jing Liang, Li Jing, Gang Liu, Fengmei Wang
OBJECTIVE: To evaluate the effects of recombinant human thrombopoietin (rhTPO) on platelet count (PLT) and liver function in acute liver failure (ALF) rats by observing the dynamic changes of PLT, thrombopoietin (TPO) and liver function during ALF. METHODS: Twenty-four male Sprague-Dawley (SD) rats were divided into model group, TPO group and interleukin-11 (IL-11) group using a random number table method, with eight rats in each group. All rats were intraperitoneally injected with D-galactosamine (D-GalN, 1 500 mg/kg, dosed within 72 hours) to induce the ALF model...
February 2024: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
https://read.qxmd.com/read/38429845/single-cell-deconvolution-algorithms-analysis-unveils-autocrine-il11-mediated-resistance-to-docetaxel-in-prostate-cancer-via-activation-of-the-jak1-stat4-pathway
#13
JOURNAL ARTICLE
Bisheng Cheng, Lingfeng Li, Tianlong Luo, Qiong Wang, Yong Luo, Shoumin Bai, Kaiwen Li, Yiming Lai, Hai Huang
BACKGROUND: Docetaxel resistance represents a significant obstacle in the treatment of prostate cancer. The intricate interplay between cytokine signalling pathways and transcriptional control mechanisms in cancer cells contributes to chemotherapeutic resistance, yet the underlying molecular determinants remain only partially understood. This study elucidated a novel resistance mechanism mediated by the autocrine interaction of interleukin-11 (IL-11) and its receptor interleukin-11 receptor subunit alpha(IL-11RA), culminating in activation of the JAK1/STAT4 signalling axis and subsequent transcriptional upregulation of the oncogene c-MYC...
March 1, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38411106/nlrp1-restricts-porcine-deltacoronavirus-infection-via-il-11-inhibiting-the-phosphorylation-of-the-erk-signaling-pathway
#14
JOURNAL ARTICLE
Haojie He, Yongfeng Li, Yunyan Chen, Jianfei Chen, Zhongyuan Li, Liang Li, Da Shi, Xin Zhang, Hongyan Shi, Mei Xue, Li Feng
Continuously emerging highly pathogenic coronaviruses remain a major threat to human and animal health. Porcine deltacoronavirus (PDCoV) is a newly emerging enterotropic swine coronavirus that causes large-scale outbreaks of severe diarrhea disease in piglets. Unlike other porcine coronaviruses, PDCoV has a wide range of species tissue tropism, including primary human cells, which poses a significant risk of cross-species transmission. Nucleotide-binding oligomerization domain-like receptor (NLR) family pyrin domain-containing 1 (NLRP1) has a key role in linking host innate immunity to microbes and the regulation of inflammatory pathways...
February 27, 2024: Journal of Virology
https://read.qxmd.com/read/38392279/the-influence-of-il-11-on-cardiac-fibrosis-in-experimental-models-a-systematic-review
#15
REVIEW
Yarlla Loyane Lira Braga, José Rodrigues do Carmo Neto, Pablo Igor Ribeiro Franco, Fernanda Rodrigues Helmo, Marlene Antônia Dos Reis, Flávia Aparecida de Oliveira, Mara Rúbia Nunes Celes, Marcos Vinícius da Silva, Juliana Reis Machado
Fibrosis is one of the main factors that impair the function of many organs. In the heart, fibrosis leads to contractile dysfunction and arrhythmias, which are important in the development of heart failure. Interleukin (IL)-11 is regulated in various heart diseases and has recently been reported to be an important cytokine in fibrosis in this organ. However, this topic has been little explored, and many questions persist. Thus, this systematic review aimed to report on possible IL-11 therapies evaluated in rodent model-induced cardiac fibrosis...
February 17, 2024: Journal of Cardiovascular Development and Disease
https://read.qxmd.com/read/38392276/cardiac-and-renal-fibrosis-the-silent-killer-in-the-cardiovascular-continuum-an-up-to-date
#16
REVIEW
Traian Chiuariu, Delia Șalaru, Carina Ureche, Laura Vasiliu, Ancuta Lupu, Vasile Valeriu Lupu, Adela Mihaela Șerban, Alexandra Zăvoi, Laura Catalina Benchea, Alexandra Clement, Bogdan-Sorin Tudurachi, Radu Andy Sascău, Cristian Stătescu
Cardiovascular disease (CVD) and chronic kidney disease (CKD) often coexist and have a major impact on patient prognosis. Organ fibrosis plays a significant role in the pathogenesis of cardio-renal syndrome (CRS), explaining the high incidence of heart failure and sudden cardiac death in these patients. Various mediators and mechanisms have been proposed as contributors to the alteration of fibroblasts and collagen turnover, varying from hemodynamic changes to the activation of the renin-angiotensin system, involvement of FGF 23, and Klotho protein or collagen deposition...
February 16, 2024: Journal of Cardiovascular Development and Disease
https://read.qxmd.com/read/38357138/correlation-between-protein-expression-profiling-of-inflammation-and-bone-metabolism-in-rheumatoid-arthritis-patients
#17
JOURNAL ARTICLE
Jie Wang, Jian Liu
OBJECTIVE: In patients with rheumatoid arthritis (RA), osteoarthrosis significantly reduces self-perception. However, the intrinsic relationship between bone metabolism and SPP and cell activity at the molecular level remains unclear. The purpose of this study was to understand the relationship between RA bone metabolic indicators and immune inflammation-related proteins. METHODS: A total of 30 patients with RA and 30 healthy controls were recruited. Four bone metabolism measures and nine proteins expression measures were collected from RA patients and healthy controls...
September 2023: African Health Sciences
https://read.qxmd.com/read/38352555/harnessing-the-regenerative-potential-of-interleukin11-to-enhance-heart-repair
#18
Kwangdeok Shin, Anjelica Rodriguez-Parks, Yu Xia, Chenyang Dong, Sunduz Kelles, Jingli Cao, Junsu Kang
Balancing between regenerative processes and fibrosis is crucial for heart repair 1 . However, strategies to regulate the balance between these two process are a barrier to the development of effective therapies for heart regeneration. While Interleukin 11 (IL11) is known as a fibrotic factor for the heart 2-4 , its contribution to heart regeneration remains poorly understood. Here, we uncovered that il11a can initiate robust regenerative programs in the zebrafish heart, including cell cycle reentry of cardiomyocytes (CMs) and coronary expansion, even in the absence of injury...
January 30, 2024: bioRxiv
https://read.qxmd.com/read/38329021/craniosynostosis-associated-variants-in-the-il-11r-complex-new-insights-and-questions
#19
JOURNAL ARTICLE
Natalie A Sims, Michael D W Griffin
Skull growth involves the expansion of both the flat calvarial bones of the skull and the fibrous marginal zones, termed sutures, between them. This process depends on co-ordinated proliferation of mesenchymal-derived progenitor cells within the sutures, and their differentiation to osteoblasts which produce the bone matrix required to expand the size of the bony plates. Defects lead to premature closure of these sutures, termed craniosynostosis, resulting in heterogeneous head shape differences due to restricted growth of one or more sutures...
February 8, 2024: FEBS Journal
https://read.qxmd.com/read/38327986/effectiveness-and-economic-evaluation-of-rhtpo-and-rhil-11-in-the-treatment-of-cancer-therapy-induced-thrombocytopenia-based-on-real-world-research
#20
JOURNAL ARTICLE
Fa-Min Gong, Fu-Yue Liu, Xue Ma, Song-Tao Ma, Hong-Tao Xiao, Gang Jiang, Ting-Ting Qi
Objective: Based on real-world research, we aimed to evaluate the effectiveness and economy of recombinant human thrombopoietin (rhTPO) and recombinant human interleukin 11 (rhIL-11) in the treatment of cancer therapy induced thrombocytopenia (CTIT). Methods: We retrospectively collected clinical data of patients with CTIT who were treated with rhTPO or rhIL-11 in a single cancer hospital from January 2020 to December 2021. Propensity score matching (PSM) was applied to eliminate confounding factors. The measurements of effectiveness analysis were the platelet compliance rate, days of medication, days of compliance, highest platelet count after medication, platelet count elevation before and after medication, and the lowest platelet count after next-cycle cancer therapy...
2024: Frontiers in Pharmacology
keyword
keyword
56969
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.